Philip Spanheimer Archives

Breast tumor cells can escape drug treatment because cells can take multiple paths through the cell cycle, and only some of these paths are blocked by the drug.

A team of UNC researchers investigated how cell cycle flexibility allows tumor cells to escape the effect of anti-cancer drugs that target cell division.

Missy Van Lokeren with her family at an event.

Missy Van Lokeren was diagnosed with metastatic breast cancer in 2018, and has became a patient advocate spreading awareness for tissue donation through the Patients And Researchers Together (PART) program.

UNC Lineberger’s Philip Spanheimer, MD, was presented with a Young Investigator Award at the Society of Surgical Oncology annual meeting.

UNC Lineberger researchers and colleagues will be presenting the latest findings from basic, translational and clinical studies at the 45th annual San Antonio Breast Cancer Symposium.

Exteriors of the UNC Lineberger and Marsico Hall buildings.

UNC Lineberger awarded 17 developmental research grants totaling nearly $1.1 million to faculty during the spring 2022 award cycle.

Tag: Philip Spanheimer

The path of escape: How breast tumor cells avoid common cancer therapy

Cancer patients donate tissue to help find new treatments

Spanheimer earns Society of Surgical Oncology Young Investigator Award

UNC Lineberger researchers present findings at San Antonio Breast Cancer Symposium

UNC Lineberger awards $1.1 million in developmental research grants